CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 70 enrolled
Drug / intervention
Lidocaine Cream 4% +1 moredrug
Likely dose
Lidocaine Cream 4% 2gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00533468
NCT00533468Phase 4Completed
CompareCT.gov

"Lidocaine 4% Cream (LMX4) vs Placebo for Pain Due to Lumbar Puncture in Infants 0-60 Days of Age."

State University of New York at Buffalo·interventional·Posted Sep 21, 2007·Updated Dec 28, 2022

In Brief

A Phase 4 clinical trial evaluating Lidocaine Cream 4% and Placebo for Pain. Completed, enrolled 70 participants across 1 site.

Detailed Summary

The study's hypothesis is LMX4 cream, a topical anesthetic cream, will reduce the pain of infants undergoing Lumbar Puncture (spinal tap).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
CollaboratorsFerndale Laboratories, Inc.

Timeline

Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 21, 2007
Enrollment StartMar 1, 2007
Primary CompletionMar 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 18.8 years ago

Interventions

Lidocaine Cream 4%drug

Topical cream, 2g applied under occlusive dressing for 20 minutes prior to the procedure

Placebodrug

inactive placebo without LMX4